[vc_row type=”vc_default” bg_type=”bg_color” bg_override=”ex-full” el_id=”about” bg_color_value=”#0A4170″ css=”.vc_custom_1750606875524{margin-top: -35px !important;}”][vc_column][vc_empty_space height=”40px”][vc_row_inner content_placement=”middle”][vc_column_inner width=”1/2″][vc_single_image image=”585″ img_size=”full” css=””][/vc_column_inner][vc_column_inner width=”1/2″][vc_column_text css=”” el_class=”about-title”]

What Is
UPAJAK?

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_column_text css=”” el_class=”white”]

Upajak (Upadacitinib) is a generic version of RINVOQ which is a selective Janus kinase (JAK) inhibitor used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, atopic dermatitis, and ankylosing spondylitis. By specifically targeting JAK1, it helps regulate immune responses and reduce inflammation more effectively than traditional treatments.

What makes Upadacitinib so effective is its oral administration, strong efficacy, and rapid symptom relief compared to older biologics (Adalimumab). It has shown superior results in achieving remission in autoimmune diseases, especially for patients who do not respond well to conventional treatments. Unlike some biologics that require injections, Upadacitinib offers convenience as a once-daily pill, improving patient adherence. Its targeted mechanism reduces excessive immune activity while maintaining a manageable safety profile. Due to its potent action and ease of use, Upadacitinib has become a one of the first choice in the treatment of chronic inflammatory diseases, significantly improving patients’ quality of life.

[/vc_column_text][vc_empty_space height=”40px”][vc_row_inner content_placement=”middle”][vc_column_inner width=”1/4″][vc_column_text css=”” el_class=”about-title”]

How
UPAJAK
Works ?

[/vc_column_text][/vc_column_inner][vc_column_inner width=”3/4″][vc_single_image image=”627″ img_size=”full” alignment=”right” css=””][/vc_column_inner][/vc_row_inner][vc_column_text css=”” el_class=”white”]

In disease states, cytokines activate JAK1 and JAK3, leading to STAT phosphorylation, gene transcription, and an inflammatory response. Due to an inflammatory response, patients often feel pain, swelling, and stiffness in the affected areas, along with fatigue and a general sense of discomfort. After JAK inhibition with Upajak, this pathway is disrupted, STAT proteins remain inactive, gene transcription is halted, and inflammation is suppressed. As a result, patients can enjoy a pain free quality life. This mechanism offers targeted control of overactive immune responses with minimal side effects.

[/vc_column_text][vc_empty_space height=”40px”][/vc_column][/vc_row][vc_row type=”vc_default” el_id=”dosage”][vc_column][vc_empty_space height=”40px”][vc_column_text css=”” el_class=”product-info”]

Recommended Dosage

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_single_image image=”625″ img_size=”full” alignment=”center” css=””][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row][vc_row type=”vc_default” el_id=”before-prescribing”][vc_column][vc_empty_space height=”40px”][vc_column_text css=”” el_class=”product-info”]

Before Prescribing Upajak

[/vc_column_text][/vc_column][/vc_row][vc_row type=”vc_default” equal_height=”yes” content_placement=”middle”][vc_column width=”1/4″ css=”.vc_custom_1750174031820{background-image: url(https://upajak.com/wp-content/uploads/2025/06/bg-design.png?id=566) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_text css=”” el_class=”left-bg”]Before starting treatment with Updacitinib, consider the following evaluatios:[/vc_column_text][/vc_column][vc_column width=”3/4″ el_class=”right-bg”][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Tuberculosis (TB): Check for active or latent TB. If positive, treat TB before starting Upadacitinib.[/bsf-info-box][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Hepatitis screening: Screen for hepatitis B and C. Do not start Upadacitinib in patients with active hepatitis B or C.[/bsf-info-box][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Complete blood count:[/bsf-info-box][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Do not start if:
– Lymphocyte count < 500 cells/mm³
– Neutrophil count < 1000 cells/mm³
– Hemoglobin < 8 g/dL[/bsf-info-box][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Liver function: Avoid use in patients with severe liver impairment (Child-Pugh C).[/bsf-info-box][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Pregnancy: Confirm pregnancy status in women of reproductive potential.[/bsf-info-box][bsf-info-box icon_type=”custom” icon_img=”id^568|url^https://upajak.com/wp-content/uploads/2025/06/icon-p.png|caption^null|alt^null|title^icon-p|description^null” img_width=”30″ pos=”left”]Immunizations: Update all vaccines as per current guidelines.[/bsf-info-box][/vc_column][/vc_row][vc_row type=”vc_default” el_id=”Leaflet”][vc_column][vc_empty_space height=”70px”][vc_column_text css=”” el_class=”product-info”]

Patient Information Leaflet

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_column_text css=””]rupajak-patient-info-leaflet[/vc_column_text][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row]